投资真的需要有信仰。不然,在逻辑走坏持续阴跌过程中,99.99%的投资者是扛不住的。这些真实地在荣昌生物(688331.SH)身上发生,2024年因现金流紧缺、商业化不及预期、产品路线摇摆等问题,荣昌迎来上市后最为艰难的时刻,股价新低之后又新低,一度杀跌至22.37元/股(2024.9.23)。而在这之前,公司股价最高曾触及95.5元/股(2023.2.2)。前后1年半的时间,荣昌跌没了3/4的...
Source Link投资真的需要有信仰。不然,在逻辑走坏持续阴跌过程中,99.99%的投资者是扛不住的。这些真实地在荣昌生物(688331.SH)身上发生,2024年因现金流紧缺、商业化不及预期、产品路线摇摆等问题,荣昌迎来上市后最为艰难的时刻,股价新低之后又新低,一度杀跌至22.37元/股(2024.9.23)。而在这之前,公司股价最高曾触及95.5元/股(2023.2.2)。前后1年半的时间,荣昌跌没了3/4的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.